Product Information
LETROZOLE 2.5 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.1511 per EA under NDC 51991075990. Its NADAC has been published 182 times since Mar 1, 2023.
FDA first approved this application on Jun 3, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991075990
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LETROZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA200161FDA Approved
6/3/2011
TE Code
AB
On Market Since
6/4/2011
Pharmacological Classes
Price Statistics
The NADAC for LETROZOLE 2.5 MG TABLET has been published 182 times since Mar 1, 2023, and over the history we have for it it has risen 47.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1511 per EA |
|---|---|
| All-time high | $0.1535 (Jul 15, 2026) |
| All-time low | $0.1009 (Jun 21, 2023) |
| 52-week high | $0.1535 |
| 52-week low | $0.1292 |
| Median price | $0.1398 |
| Average price | $0.1334 |
| Largest weekly change | +32.3% (Nov 22, 2023) |
| Weeks tracked | 182 |
| Tracking since | Mar 1, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LETROZOLE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LETROZOLE 2.5 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $0.1511 per EA (NDC 51991075990), effective Aug 19, 2026.
How has the price of LETROZOLE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LETROZOLE 2.5 MG TABLET has risen 47.7%. It has been tracked across 182 weekly CMS publications since Mar 1, 2023.
What are the highest and lowest recorded NADAC prices for LETROZOLE 2.5 MG TABLET?
Since Mar 1, 2023, the NADAC for LETROZOLE 2.5 MG TABLET has ranged from a low of $0.1009 (Jun 21, 2023) to a high of $0.1535 (Jul 15, 2026), with a median of $0.1398 per EA.
Are there cheaper alternatives to LETROZOLE 2.5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LETROZOLE 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LETROZOLE 2.5 MG TABLET?
LETROZOLE 2.5 MG TABLET (NDC 51991075990) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.